Clinical Trial Update: Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating adaptive SBRT with chemoimmunotherapy for extensive-stage small-cell lung cancer has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Extensive-stage Small-cell Lung Cancer | Phase 1 | Status: SUSPENDED